Growth Metrics

Rockwell Medical (RMTI) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Rockwell Medical (RMTI) over the last 6 years, with Sep 2025 value amounting to $124,000.

  • Rockwell Medical's Gains from Investment Securities fell 11.43% to $124,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $446,000, marking a year-over-year decrease of 64.49%. This contributed to the annual value of $2.0 million for FY2024, which is 83.24% up from last year.
  • As of Q3 2025, Rockwell Medical's Gains from Investment Securities stood at $124,000, which was down 16.22% from $148,000 recorded in Q2 2025.
  • Rockwell Medical's Gains from Investment Securities' 5-year high stood at $840,000 during Q3 2023, with a 5-year trough of $10,000 in Q2 2022.
  • Over the past 3 years, Rockwell Medical's median Gains from Investment Securities value was $138,000 (recorded in 2024), while the average stood at $196,000.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 1,200.00% in 2023, then plummeted by 83.33% in 2024.
  • Rockwell Medical's Gains from Investment Securities (Quarterly) stood at $57,000 in 2021, then soared by 431.58% to $303,000 in 2022, then spiked by 182.83% to $840,000 in 2023, then plummeted by 83.33% to $28,000 in 2024, then declined by 11.43% to $124,000 in 2025.
  • Its last three reported values are $124,000 in Q3 2025, $148,000 for Q2 2025, and $146,000 during Q1 2025.